Related Experiment Videos
Tolerance induction through simultaneous double bone marrow transplantation with two-signal blockade
Eun-Na Lee1, Jienny Lee, Eun-Young Kim
1Transplantation Research Center, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Ku, Seoul 135-710, Republic of Korea.
Immunology Letters
|November 2, 2005
Summary
Multi-donor bone marrow cells (BMCs) can achieve mixed chimerism and induce donor-specific tolerance in mice. This novel approach overcomes challenges in transplantation tolerance, paving the way for improved allograft acceptance.
Area of Science:
- Immunology
- Transplantation Science
- Cellular Biology
Background:
- Cotransplantation of donor bone marrow cells (BMCs) is a promising strategy for inducing clinical tolerance in allograft recipients.
- However, current methods face challenges including host conditioning toxicity, engraftment failure, graft-versus-host disease (GVHD), and limited donor cell accessibility.
Purpose of the Study:
- To investigate the simultaneous engraftment of multi-donor BMCs.
- To determine if this leads to chimerism-based tolerance using a previously validated tolerogenic protocol.
Main Methods:
- Utilized a murine model with C57BL/6 (H-2b) host mice.
- Administered Busulfan conditioning and a two-signal blockade (anti-CD45RB and anti-CD154 monoclonal antibodies).
- Transplanted BMCs from BALB/c (H-2d) and CBA (H-2k) mice.
Main Results:
- Demonstrated successful establishment of mixed-type, multi-lineage double chimerism.
- Showed induction of immunological donor-specific tolerance.
- Achieved tolerance to fully MHC-mismatched skin allografts.
Conclusions:
- Simultaneous engraftment of BMCs from multiple donors can induce robust chimerism.
- This strategy effectively establishes donor-specific tolerance, overcoming major transplantation barriers.
- The findings support a novel approach for improving allograft acceptance and reducing rejection.